Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 601

The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.

Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic

Open access
Weiss, Carsten, Carriere, Marie, Fusco, Laura, Capua, Ilaria, Regla-Nava, Jose Angel, Pasquali, Matteo, Scott, James A., Vitale, Flavia, Unal, Mehmet Altay, Mattevi, Cecilia, Bedognetti, Davide, Merkoçi, Arben, Tasciotti, Ennio, Yilmazer, Açelya, Gogotsi, Yury, Stellacci, Francesco, Delogu, Lucia Gemma·2020·ACS Nano

Abstract

The COVID-19 outbreak has fueled a global demand for effective diagnosis and treatment as well as mitigation of the spread of infection, all through large-scale approaches such as specific alternative antiviral methods and classical disinfection protocols.Based on an abundance of engineered materials identifiable by their useful physicochemical properties through versatile chemical functionalization, nanotechnology offers a number of approaches to cope with this emergency.Here, through a multidisciplinary Perspective encompassing diverse fields such as virology, biology, medicine, engineering, chemistry, materials science, and computational science, we outline how nanotechnology-based strategies can support the fight against COVID-19, as well as infectious diseases in general, including future pandemics.Considering what we know so far about the life cycle of the virus, we envision key steps where nanotechnology could counter the disease.First, nanoparticles (NPs) can offer alternative methods to classical disinfection protocols used in healthcare settings, thanks to their intrinsic antipathogenic properties and/or their ability to inactivate viruses, bacteria, fungi, or yeasts either photothermally or via photocatalysis-induced reactive oxygen species (ROS) generation.Nanotechnology tools to inactivate SARS-CoV-2 in patients could also be explored.In this case, nanomaterials could be used to deliver drugs to the pulmonary system to inhibit interaction between angiotensin-converting enzyme 2 (ACE2) receptors and viral S protein.Moreover, the concept of "nanoimmunity by design" can help us to design materials for immune modulation, either stimulating or suppressing the immune response, which would find applications in the context of vaccine development for SARS-CoV-2 or in counteracting the cytokine storm, respectively.In addition to disease prevention and therapeutic potential, nanotechnology has important roles in diagnostics, with potential to support the development of simple, fast, and cost-effective nanotechnology-based assays to monitor the presence of SARS-CoV-2 and related biomarkers.In summary, nanotechnology is critical in counteracting COVID-19 and will be vital when preparing for future pandemics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsnano.0c03697

Cites

204 of 204 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–204 of 204

Cited by

See all 601

Metadata

Authors
Weiss, C., Carriere, M., Fusco, L., Capua, I., Regla-Nava, J. A., Pasquali, M., Scott, J. A., Vitale, F., Unal, M. A., Mattevi, C., Bedognetti, D., Merkoçi, A., Tasciotti, E., Yilmazer, A., Gogotsi, Y., Stellacci, F., & Delogu, L. G.
Venue
ACS Nano
Published
2020-06-10
Volume
14
Issue
6
Pages
6383-6406
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W3033019032
Cited by
601
References
204
FWCI
14.67
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.